期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

单倍体异基因造血干细胞移植治疗急性白血病疗效观察 被引量：2

Study on HLA-haploidentical hematopoietic stem cell transplantation in treatment of acute leukemia
下载PDF
导出
摘要 目的观察单倍体异基因造血干细胞移植(Haplo-SCT)治疗急性白血病的疗效。方法对我科2006年6月至2007年12月5例急性白血病患者进行单倍体异基因造血干细胞移植,预处理方案:改良马利兰与环磷酰胺(BU/CY)方案。移植物抗宿主病(GVHD)预防:环孢素A、短程甲氨喋呤、霉酚酸酯和抗-CD25抗体。结果5例患者全部获得造血重建。1例因合并Ⅲ度肠道急性移植物抗宿主病死亡,其余4例随访20～30月,目前均无病存活。结论单倍体异基因造血干细胞移植造血重建稳定,严重并发症少,可作为造血干细胞来源。 Objective To analyze the engraftment time and result of HLA - haploidentical hematopoietic stem cell transplantation in treat- ment of acute leukemia. Methods Five cases of acute leukemia had undergone Haplo - SCT in this hospital during June, 2006 to December 2007. The prophylaxis against GVHD was by applying Ciclosporin A （CSA） plus methotrexate, Mycophenolate Mofeil（MMF） and Anti -CD25 monoclonal antibody（ Zenapax）. Results Engraftment was obtained in all patients. One patient died of grade Ⅲ acute intestinal GVHD. The remaining 4 patients were survived with complete remission during the period of follow up for 20 - 30 months. Conclusion These observations suggested that the hematopoietic reconstitution should be done earlier and more durable in haploidentical SCT, and haploidentieal hematopoietic stem cell donor is possible to be served as its source.
作者 孙丽华 王钧 孟庆祥
机构地区 北京大学深圳医院血液科
出处 《临床和实验医学杂志》 2009年第8期19-20,共2页 Journal of Clinical and Experimental Medicine
关键词 急性白血病 异基因造血干细胞移植 单倍体 Acute leukemia Allogeneic stem cell transplantation Haploidentical
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献3

二级参考文献29

  • 1Aversa F, Tabilio A, Velardi A, et al. Treatment of highrisk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype [J]. N Engl J Med, 1998,339:1186-1193.
  • 2Eyrich M, Croner T, Leiler C, et al. Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells fro
  • 3Lewalle P,triffet A, Delforge A,et al. Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study [J ]. Bone Marrow Transplantation, 2003; 31:39-44.
  • 4纪树荃.一个新型单倍体造血干细胞移植方案及移植结果[C]..全国首届半匹配造血干细胞移植和非亲髓性移植学术研讨会[C].北京,2002.10-20.
  • 5Martelli MF, Reisner Y. Haploidentical ‘megadose' CD+34 cell transplants for patients with acute leukemia [J].Leukemia,2002,16:404-405.
  • 6Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med, 1993, 328: 593-602.
  • 7Beatty PG. Marrow transplantation using volunteer unrelated donors in a comparison of mismatched family donor transplants:a Seattle perspective. Bone Marrow Transplant, 1994, 14 Suppl 4: S39-41.
  • 8Aversa F, Tabilio A, Velardi A, et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med,1998, 339: 1186-1193.
  • 9Mineishi S, Longo WL, Atkinson ME, et al. Addition of highdose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Bone Marrow Transplant, 1999, 23: 1217-1222.
  • 10Hassan HT,Stockschlader M,Schleimer B,et al. Comparison of the content and subpopulation of CD3 and CD34 positive cells in bone marrow harvest and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors. Transplant Immunol, 1996,

共引文献74

同被引文献16

  • 1Chen X, Zhang C, Zhang X, et al. Role of anfi-thymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignandes [J]. Biol Blood Marrow Transplant, 2009, 15(2): 266-273.
  • 2Champlin R, Khouri I, Kornblau S, etal. Reinventing bone marrow transplantation: reducing toxicity using non-myeloablative, preparative regimens and induction of graft versus- malignancy[J]. Curt Opin Oncol, 1999, 11(2): 87-95.
  • 3Bensinger WI, Weaver CH, Appetbaurn FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor [J]. Blood, 1995, 85(6): 1655-1658.
  • 4Anderlini P, DOnato M, Chan KW, et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim:the M.D. Anderson Cancer Center experience [J]. Transfus, 1999 39(6) : 555-560.
  • 5Chen XH, Gao L, Zhang X, et al. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation [J]. Blood Cells Mol Dis, 2009, 43(1): 98-104.
  • 6陆道培.白血病的骨髓移植治疗(Ⅰ)-适应症、预处理与移植技术[M]//陆道培.自血病治疗学.北京:科学出版社,1992.330-333.
  • 7钟建庭.自体骨髓移植的适应症和基本技术[M]//达万明.自体造血干细胞移植.甘肃:甘肃科学技术出版社,1995.21-24.
  • 8Regidor C, Posada M, Monteagudo D, et al. Umbilical cord blood banking for unrelated transplantation: Evaluation of cell separation and storage methods [J]. Exp Hemat, 1999, 27(2): 380-385.
  • 9刘开彦.脐血造血干细胞移植[M]//达万明,裴雪涛.外周血干细胞移植.北京:人民卫生出版社,2000.304-305.
  • 10Xue-dong wu,Liu Huaying,yue-lin he,xiao-qin feng,Ch en Geyu,shi lei,Su Qingxia,fan-yi meng,chun-fu li.Be ar bile acid to prevent heavy Mediterranean anemia tran splanted to oxygen after hepatic vein occlusion disease. Journal of practical medicine . 2009

引证文献2

二级引证文献10

临床和实验医学杂志
2009年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部